Creo Medical Group PLC (1RC.SG)

0.3940 0.0000 (0.00%) As of 02:34PM CEST. Market open.

Creo Medical Group PLC

Creo House
Unit 2, Beaufort Park Beaufort Park Way
Chepstow NP16 5UH
United Kingdom
44 12 9160 6005
https://creomedical.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 279

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Craig Jonathan Gulliford	CEO & Executive Director	552.21k	N/A	1970
Prof. Christopher Paul Hancock	Founder, CTO & Executive Director	420.8k	N/A	1967
Mr. Richard John Rees ACA	CFO, Company Secretary & Executive Director	420.36k	N/A	1976
Mr. David Gerard Woods	Chief Commercial Officer & Executive Director	521.51k	N/A	1965
Mr. Phil Hales	Sales & Marketing Director	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for flexible endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device designed for soft tissue ablation; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highly perfused tissues. In addition, it provides endotherapy accessories comprising ScopeSnare, an energy-based polypectomy snares; ScopeSnare Cold, a cutting wire for use in endoscopically in the removal of diminutive, sessile and pedunculated polyps, and tissue from within the GI tract; ScopeClip, a single-use rotational and repositionable hemoclips; ScopeBite, a portfolio of biopsy forceps; ScopeGrasp, a portfolio of grasping forceps; and ScopeInject, an injection needle. Creo Medical Group PLC was founded in 2003 and is based in Chepstow, the United Kingdom.

Corporate Governance

Creo Medical Group PLC’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.